DE3869895D1 - Cephalosporinderivate mit verbesserter pharmakokinetik, verfahren zur ihrer herstellung, sie enthaltende pharmazeutische praeparate und zwischenverbindung. - Google Patents

Cephalosporinderivate mit verbesserter pharmakokinetik, verfahren zur ihrer herstellung, sie enthaltende pharmazeutische praeparate und zwischenverbindung.

Info

Publication number
DE3869895D1
DE3869895D1 DE8888402527T DE3869895T DE3869895D1 DE 3869895 D1 DE3869895 D1 DE 3869895D1 DE 8888402527 T DE8888402527 T DE 8888402527T DE 3869895 T DE3869895 T DE 3869895T DE 3869895 D1 DE3869895 D1 DE 3869895D1
Authority
DE
Germany
Prior art keywords
production
same
pharmaceutical preparations
intermediate connection
preparations containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8888402527T
Other languages
English (en)
Inventor
Bernard Labeeuw
Ali Salhi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi SA
Original Assignee
Sanofi SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi SA filed Critical Sanofi SA
Application granted granted Critical
Publication of DE3869895D1 publication Critical patent/DE3869895D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • C07D501/34—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/31—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atoms of the sulfonamide groups bound to acyclic carbon atoms
    • C07C311/32—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atoms of the sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
DE8888402527T 1987-10-08 1988-10-06 Cephalosporinderivate mit verbesserter pharmakokinetik, verfahren zur ihrer herstellung, sie enthaltende pharmazeutische praeparate und zwischenverbindung. Expired - Fee Related DE3869895D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8713925A FR2621589B1 (fr) 1987-10-08 1987-10-08 Derives des cephalosporines a pharmacocinetique amelioree, procede pour leur preparation et compositions pharmaceutiques les contenant

Publications (1)

Publication Number Publication Date
DE3869895D1 true DE3869895D1 (de) 1992-05-14

Family

ID=9355637

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8888402527T Expired - Fee Related DE3869895D1 (de) 1987-10-08 1988-10-06 Cephalosporinderivate mit verbesserter pharmakokinetik, verfahren zur ihrer herstellung, sie enthaltende pharmazeutische praeparate und zwischenverbindung.

Country Status (19)

Country Link
US (1) US5079241A (de)
EP (1) EP0311521B1 (de)
JP (1) JPH0637502B2 (de)
KR (1) KR970004044B1 (de)
AR (1) AR246271A1 (de)
AT (1) ATE74607T1 (de)
AU (2) AU612414B2 (de)
DE (1) DE3869895D1 (de)
DK (1) DK555288A (de)
ES (1) ES2036702T3 (de)
FI (1) FI89715C (de)
FR (1) FR2621589B1 (de)
GR (1) GR3005122T3 (de)
IE (1) IE61508B1 (de)
IL (2) IL103721A (de)
NO (1) NO171275C (de)
NZ (1) NZ226487A (de)
PT (1) PT88694B (de)
ZA (1) ZA887546B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4282699B2 (ja) 2006-09-01 2009-06-24 株式会社東芝 半導体装置
WO2015035376A2 (en) 2013-09-09 2015-03-12 Calixa Therapeutics, Inc. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4024133A (en) * 1971-05-14 1977-05-17 Glaxo Laboratories Limited 7β-[2-Etherified oximino-2-(thienyl-,furyl- or pyridylacetamido)]cephalosporins
US3971778A (en) * 1972-05-12 1976-07-27 Glaxo Laboratories Limited Cephalosporins having (α-etherified oximino)acylamido groups at the 7-position
US4033950A (en) * 1971-05-14 1977-07-05 Glaxo Laboratories Limited 3-Hydroxymethyl-7β-(2-alkoxy-or benzyloxyimino-2-arylacetamido)ceph-3-em-4-carboxylic acids and salts thereof
US4138555A (en) * 1971-05-14 1979-02-06 Glaxo Laboratories, Limited (6R,7R)-7-[2-aryl-2-(etherified oximino)acetamido]-3-carbamoyloxymethylceph-3-em-4-carboxylic acid 1-oxides
DK154939C (da) * 1974-12-19 1989-06-12 Takeda Chemical Industries Ltd Analogifremgangsmaade til fremstilling af thiazolylacetamido-cephemforbindelser eller farmaceutisk acceptable salte eller estere deraf
US4203899A (en) * 1974-12-19 1980-05-20 Takeda Chemical Industries, Ltd. Thiazolylacetamido compounds
JPS5760345B2 (de) * 1974-12-19 1982-12-18 Takeda Chemical Industries Ltd
US4668783A (en) * 1974-12-19 1987-05-26 Takeda Chemical Industries, Ltd. Thiazolylacetamido cephalosporin compounds
US4298606A (en) * 1974-12-19 1981-11-03 Takeda Chemical Industries, Ltd. Thiazolylacetamido compounds
US4166115A (en) * 1976-04-12 1979-08-28 Fujisawa Pharmaceutical Co., Ltd. Syn 7-oxoimino substituted derivatives of cephalosporanic acid
US4871860A (en) * 1976-04-12 1989-10-03 Fujisawa Pharmaceutical Co., Ltd. Syn-isomer of 3,7-disubstituted-3-cephem-4-caroxylic acid compounds and processes for the preparation thereof
US4493833A (en) * 1976-04-12 1985-01-15 Fujisawa Pharmaceutical Co., Ltd. Syn-isomer of 3,7-disubstituted-3-cephem-4-carboxylic acid compounds
US4304770A (en) * 1976-04-12 1981-12-08 Fujisawa Pharmaceutical Co., Ltd. Syn-isomer of 3,7-disubstituted-3-cephem-4-carboxylic acid compounds and processes for the preparation thereof
US4331664A (en) * 1976-04-12 1982-05-25 Fujisawa Pharmaceutical Co., Ltd. Syn isomer of 7-[2-cyclo(lower) alkoxyimino-2-(2-amino-or substituted aminothiazol-4-yl)acetamido]-3-lower alkanoyloxymethyl or heterocyclicthiomethyl-3-cephem-4-carboxylic acid compounds
US4804752A (en) * 1976-04-12 1989-02-14 Fujisawa Pharmaceutical Co., Ltd. Syn-isomer of 3,7-disubstituted-3-cephem-4-carboxylic acid compounds and processes for the preparation thereof
US4364943A (en) * 1976-04-12 1982-12-21 Fujisawa Pharmaceutical Co., Ltd. Syn-isomer of 7-[2-alkoxyimino-2-(2-amino-alkanoylamino-or haloalkanoylamino-thiazol-4-yl) acetamids]-3-[hexanoyl-, or phenylalkanoyl-oxymethyl or benzothiazolylthiomethyl]-3-cephem-4-carboxylic acid
DE2760484C2 (de) * 1976-04-14 1992-12-03 Takeda Chemical Industries, Ltd., Osaka, Jp
DE2714880A1 (de) * 1977-04-02 1978-10-26 Hoechst Ag Cephemderivate und verfahren zu ihrer herstellung
US4655166A (en) * 1979-12-26 1987-04-07 Hitachi, Ltd. Apparatus for preventing oscillation of running strip
FR2546520B1 (fr) * 1983-05-27 1985-08-30 Sanofi Sa Nouveaux composes antibiotiques derives des cephalosporines
FR2570702B1 (fr) * 1984-09-27 1987-01-09 Sanofi Sa Derives des cephalosporines, procedes d'obtention et leur application a titre d'antibiotiques
ZA877987B (en) * 1986-11-12 1988-08-31 Ici Pharma Antibiotic compounds
FR2607135B1 (fr) * 1986-11-20 1989-04-28 Sanofi Sa Nouveaux derives des cephalosporines a pharmacocinetique amelioree, procede pour leur preparation et compositions pharmaceutiques les contenant
ZA884093B (en) * 1987-06-16 1989-04-26 Hoffmann La Roche Acyl derivatives

Also Published As

Publication number Publication date
PT88694A (pt) 1988-11-01
AU2349588A (en) 1989-04-13
KR970004044B1 (ko) 1997-03-24
JPH0637502B2 (ja) 1994-05-18
AU637915B2 (en) 1993-06-10
IL87975A0 (en) 1989-03-31
GR3005122T3 (de) 1993-05-24
ZA887546B (en) 1989-06-28
DK555288A (da) 1989-04-09
IL103721A (en) 1994-06-24
NO171275B (no) 1992-11-09
FI884614A0 (fi) 1988-10-07
FI89715B (fi) 1993-07-30
NO884486L (no) 1989-04-10
NZ226487A (en) 1990-08-28
IL87975A (en) 1993-04-04
AU612414B2 (en) 1991-07-11
FR2621589A1 (fr) 1989-04-14
AU7945191A (en) 1991-09-12
PT88694B (pt) 1992-12-31
FR2621589B1 (fr) 1990-03-02
IE61508B1 (en) 1994-11-02
ES2036702T3 (es) 1993-06-01
IE883046L (en) 1989-04-08
KR890006656A (ko) 1989-06-15
US5079241A (en) 1992-01-07
NO884486D0 (no) 1988-10-07
DK555288D0 (da) 1988-10-04
FI884614A (fi) 1989-04-09
EP0311521B1 (de) 1992-04-08
JPH01128985A (ja) 1989-05-22
FI89715C (fi) 1993-11-10
EP0311521A1 (de) 1989-04-12
AR246271A1 (es) 1994-07-29
ATE74607T1 (de) 1992-04-15
NO171275C (no) 1993-02-17

Similar Documents

Publication Publication Date Title
DE68904104D1 (de) Phenol-substituierte gem-diphosphonat-derivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel.
ATA315488A (de) Neue adenosinderivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische praeparate
DE3860503D1 (de) 10-dihydro-10-deoxo-11-azaerythronolid-a-verbindungen,verfahren und zwischenprodukte zu ihrer herstellung und ihre verwendung in arzneimitteln und in deren herstellung.
DE58904567D1 (de) Quinuclidine, ihre verwendung als arzneimittel und verfahren zu ihrer herstellung.
ATA125988A (de) Pharmazeutische cefuroximaxetil-zusammensetzung und verfahren zu ihrer herstellung
DE3682874D1 (de) Pyranoindolizinderivate und verfahren zu ihrer herstellung.
DE3483899D1 (de) Cephalosporinderivate, verfahren zu ihrer herstellung und pharmazeutische praeparate.
DE3782994D1 (de) Erythromycin-a-derivate und verfahren zu ihrer herstellung.
DE3788261D1 (de) Cephemderivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Präparate.
DE3485860D1 (de) Cephalosporinverbindungen, verfahren zu ihrer herstellung und pharmazeutishe praeparate.
DE3881950D1 (de) Azabicyclische verbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen.
DE3771376D1 (de) Indol-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DE3484925D1 (de) Pyrazolochinoline, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zubereitungen.
DE3767789D1 (de) Substituierte aminodihydrooxazole, -thiazole und -imidazole, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.
DE68901039D1 (de) Indolylpiperidin-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische verbindungen.
DE3576686D1 (de) Chinolinone, verfahren zu ihrer herstellung und die sie enthaltenden pharmazeutischen praeparate.
DE3766299D1 (de) 4-chinolon-3-carbonsaeurederivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
ATE41654T1 (de) All-cis-1,3,5-triamino2,4,6-cyclohexantriolderivate, ihre verwendung, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.
DE3674521D1 (de) 6-phenoxymethyl-4-hydroxytetrahydropyran-2-one, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel, pharmazeutische praeparate und zwischenprodukte.
DE3670638D1 (de) Indol-3-yl-chinazolin-1,4-benzodiazepin-5,13-dione, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen.
DE3670635D1 (de) Neue benzisoselenazolonyl-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
DE3481418D1 (de) Substituierte spiropyridinderivate, diese enthaltende pharmazeutische zubereitungen, verfahren zu ihrer herstellung und zubereitungen.
DE3681701D1 (de) Chinazolin-derivate, verfahren zu ihrer herstellung, sie enthaltende pharmazeutische praeparate und ihre verwendung.
DE3380989D1 (de) 2-aminobenzosaeurederivate, verfahren zu ihrer herstellung und pharmazeutische zubereitungen.
DE3774359D1 (de) 3-(1h-tetrazol-5-yl)oxanilsaeure, salze, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.

Legal Events

Date Code Title Description
8380 Miscellaneous part iii

Free format text: DER PATENTINHABER LAUTET RICHTIG: ELF SANOFI, PARIS, FR

8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee